A Phase IIb Clinical Study of PTS (Para-Toluenesulfonamide Injection), A Novel Local Invasive Anticancer Drug, Administered Locally and Intratumorally to Patients With Advanced Lung Cancer

Trial Profile

A Phase IIb Clinical Study of PTS (Para-Toluenesulfonamide Injection), A Novel Local Invasive Anticancer Drug, Administered Locally and Intratumorally to Patients With Advanced Lung Cancer

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Apr 2016

At a glance

  • Drugs P-toluenesulfonamide (Primary)
  • Indications Lung cancer; Malignant pleural effusion
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 22 Jan 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top